In conclusion, when IS occurs, the administration of PAS840 can effectively inhibit the inflammasome pathway, reduce the occurrence and development of brain inflammation, activate neurotrophic and vascular endothelial growth factor pathways, protect brain nerve cells, and mitigate injury to the BBB. The gene discussed is VEGFA; the disease is brain inflammatory disease.